Experimental Hematology

Experimental Hematology is the official journal of the ISEH – Society for Hematology and Stem Cells, published by Elsevier, founded in 1972 and devoted to experimental research on normal and malignant hematopoiesis, hematopoietic stem cells and their microenvironment, with a 2025 impact factor of 2.7《实验血液学》（Experimental Hematology）是国际实验血液学学会（ISEH）的官方会刊，由 Elsevier 出版，1972 年创刊，专注正常与恶性造血、造血干细胞及其微环境的实验研究，2025 年影响因子为 2.7。

Scope

• Its goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, the mechanisms that contribute to haematological diseases and new approaches to their treatment其宗旨是报道关于正常血细胞如何生成、其生成如何被正常调控、促成血液病的机制以及新的治疗途径的新见解。
• Specific topics include developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, the in vitro behaviour of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics and bioengineering approaches具体主题包括发育与衰老过程、干细胞生物学、内在与外在调控机制分析、原代细胞的体外行为、克隆追踪、分子与组学分析、代谢、表观遗传与生物工程方法。
• Further topics are studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues进一步主题包括模式生物研究、新的临床观察、移植生物学与新的治疗途径。
• The journal's scientific categories include Stem Cells, Experimental Stem Cell Transplantation, Normal Hematopoiesis, Malignant Hematopoiesis, Microenvironment and Niche, and Systems Biology该刊的科学分类包括干细胞、实验性干细胞移植、正常造血、恶性造血、微环境与龛以及系统生物学。
• They also cover Genomics and Proteomics of Hematopoiesis, Immunobiology and Immunotherapy, Gene Therapy, Clinical Investigations and New Techniques and Technologies此外还涵盖造血的基因组学与蛋白质组学、免疫生物学与免疫治疗、基因治疗、临床研究以及新技术与新方法。
• Article types are Research Articles, Brief Communications limited to 1500 words with three figures and tables and 30 references, Reviews and Perspectives of about 4000 words, and a Fast-Track submission that reaches a decision within seven to ten days文章类型包括研究论文、限 1500 词并含三个图表与 30 条参考文献的短通讯、约 4000 词的综述与观点，以及可在七至十天内作出决定的快速通道投稿。

History

• Its first issue appeared in 1972, the same year the International Society for Experimental Hematology held its first annual meeting in Milwaukee with 85 scientists from ten countries其首期于 1972 年出版，同年国际实验血液学学会在密尔沃基举办首届年会，有来自十个国家的 85 位科学家参会。^[1]
• The National Library of Medicine records the volume year as 1973, so the first-issue year and the volume-1 year differ, and the title has never been changed, although the journal superseded an earlier publication of the same name issued in Oak Ridge, Tennessee美国国家医学图书馆将卷年记为 1973，故首期年与第一卷卷年口径不同；刊名自创刊至今未变，不过本刊继任了一本早年在田纳西州橡树岭出版的同名刊物。
• The founding publisher was Munksgaard of Copenhagen and from 1999 the journal has been published by Elsevier in Amsterdam, with no third-party takeover or renaming创刊出版方为哥本哈根的 Munksgaard，自 1999 年起由阿姆斯特丹的 Elsevier 出版，无第三方收购或更名节点。
• It has been issued twelve times a year as a monthly since 1999, after a bimonthly schedule from 1975 and thirteen or fourteen issues a year in the early 1990s该刊自 1999 年起每年出十二期即月刊，此前曾于 1975 年起双月刊发行，并在 1990 年代初期为每年十三或十四期。
• Its impact factor rose from 2.1 in 2024 to 2.7 in 2025, following 2.6 in 2022 and 2.5 in 2023其影响因子由 2024 年的 2.1 升至 2025 年的 2.7，2022 年与 2023 年分别为 2.6 与 2.5。
• It remains a subscription journal with an optional Gold open access route for individual articles, and active ISEH members receive a subscription with their membership该刊仍以订阅制出版，个别文章可选金色开放获取，ISEH 有效会员随会籍获赠订阅。

Editors

• The editor-in-chief is Toshio Suda, MD, PhD, of the Institute of Hematology, Chinese Academy of Medical Sciences, whose research concerns hematopoietic stem cell biology, stress hematopoiesis and the stem cell niche现任主编为 Toshio Suda（医学博士、博士），任职于中国医学科学院血液学研究所，研究方向为造血干细胞生物学、应激造血与干细胞龛。^[2]
• The chief associate editor is Keisuke Ito of the Albert Einstein College of Medicine in the United States, and the managing editor is Katie Pegram首席副编辑为美国爱因斯坦医学院的 Keisuke Ito，责任编辑为 Katie Pegram。
• Elsevier's Guide for Authors still names Connie J. Eaves of the Terry Fox Laboratory at the BC Cancer Research Centre in Vancouver as the corresponding editor, which appears to be an outdated entry given the 2023 leadership transitionElsevier 的投稿指南仍将温哥华 BC 癌症研究中心 Terry Fox 实验室的 Connie J. Eaves 列为通讯主编，考虑到 2023 年的换届，此应为未更新的旧值。^[3]
• Known past editors-in-chief include Keith Humphries around 2016, Connie J. Eaves until 2023 and Toshio Suda from 2023已知历任主编包括 2016 年前后的 Keith Humphries、至 2023 年卸任的 Connie J. Eaves 以及 2023 年起任职的 Toshio Suda。
• Peer review is single anonymised, so authors' names are seen by reviewers while reviewers' names are not disclosed to authors, and manuscripts usually reach a decision within four to six weeks同行评审为单侧知情式，即作者姓名对评审人可见而评审人身份对作者保密，稿件通常在四至六周内获得决定。
• Regular submissions carry a US$50 submission fee that is waived for invited and ISEH member papers, and reviews and perspectives are mostly commissioned by the editor-in-chief常规投稿收取 50 美元投稿费，受邀稿件与 ISEH 会员论文免收，综述与观点文章多由主编约稿。